O. Mondiale-de-la-santé, Rapport mondial sur le diabète, 2016.

A. Association, Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, pp.62-69, 2010.

D. Meyts, P. Whittaker, and J. , Structural biology of insulin and IGF1 receptors: implications for drug design, Nature Reviews Drug Discovery, vol.297, issue.10, pp.769-83, 2002.
DOI : 10.1126/science.1074611

S. Hubbard, Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog, The EMBO Journal, vol.16, issue.18, pp.5572-81, 1997.
DOI : 10.1093/emboj/16.18.5572

A. Saltiel and C. Kahn, Insulin signalling and the regulation of glucose and lipid metabolism, Nature, vol.414, issue.6865, pp.799-806, 2001.
DOI : 10.1038/414799a

R. Denton and J. Tavaré, Does Mitogen-Activated-Protein Kinase have a Role in Insulin Action?, FEBS J, vol.227, issue.3, pp.597-611, 1995.

D. Lazar, R. Wiese, M. Brady, C. Mastick, S. Waters et al., Mitogen-activated Protein Kinase Kinase Inhibition Does Not Block the Stimulation of Glucose Utilization by Insulin, Journal of Biological Chemistry, vol.268, issue.35, pp.20801-20808, 1995.
DOI : 10.1021/bi00184a031

C. Postic, F. Mauvais-jarvis, and J. Girard, Que nous apprennent les souris génétiquement modifiées sur la physiopathologie du diabète de type 2 ? Médecine Thérapeutique Endocrinol, pp.53-62, 2002.

A. Krook, M. Björnholm, D. Galuska, X. Jiang, R. Fahlman et al., Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients, Diabetes, vol.49, issue.2, pp.284-92, 2000.
DOI : 10.2337/diabetes.49.2.284

K. Cusi, K. Maezono, A. Osman, M. Pendergrass, M. Patti et al., Insulin resistance differentially affects the PI 3-kinase??? and MAP kinase???mediated signaling in human muscle, Journal of Clinical Investigation, vol.105, issue.3, pp.311-331, 2000.
DOI : 10.1172/JCI7535

C. Wang, M. Goalstone, and B. Draznin, Molecular Mechanisms of Insulin Resistance That Impact Cardiovascular Biology, Diabetes, vol.53, issue.11, pp.2735-2775, 2004.
DOI : 10.2337/diabetes.53.11.2735

D. Rothman, I. Magnusson, G. Cline, D. Gerard, C. Kahn et al., Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulindependent diabetes mellitus, Proc Natl Acad Sci Feb, vol.1492, issue.4, pp.983-990, 1995.

R. Defronzo, From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus, Diabetes, vol.58, issue.4, pp.773-95, 2009.
DOI : 10.2337/db09-9028

P. Staehr, O. Hother-nielsen, K. Levin, J. Holst, and H. Beck-nielsen, Assessment of Hepatic Insulin Action in Obese Type 2 Diabetic Patients, Diabetes, vol.50, issue.6, pp.1363-70, 2001.
DOI : 10.2337/diabetes.50.6.1363

R. Defronzo, E. Ferrannini, and D. Simonson, Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: Contributions of excessive hepatic glucose production and impaired tissue glucose uptake, Metabolism, vol.38, issue.4, pp.387-95, 1989.
DOI : 10.1016/0026-0495(89)90129-7

I. Magnusson, D. Rothman, L. Katz, R. Shulman, and G. Shulman, Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study., Journal of Clinical Investigation, vol.90, issue.4, pp.1323-1330, 1992.
DOI : 10.1172/JCI115997

R. Defronzo, From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus, Diabetes, vol.58, issue.4, pp.773-95, 2009.
DOI : 10.2337/db09-9028

J. Clore, J. Stillman, and H. Sugerman, Glucose-6-phosphatase flux in vitro is increased in type 2 diabetes, Diabetes, vol.49, issue.6, pp.969-74, 2000.
DOI : 10.2337/diabetes.49.6.969

A. Gastaldelli, S. Baldi, M. Pettiti, E. Toschi, S. Camastra et al., Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study, Diabetes, vol.49, issue.8, pp.1367-73, 2000.
DOI : 10.2337/diabetes.49.8.1367

M. Matsuda, R. Defronzo, L. Glass, A. Consoli, M. Giordano et al., Glucagon dose-response curve for hepatic glucose production and glucose disposal in type 2 diabetic patients and normal individuals, Metabolism, vol.51, issue.9, pp.1111-1120, 2002.
DOI : 10.1053/meta.2002.34700

J. Williamson, R. Scholz, and E. Browning, Control mechanisms of gluconeogenesis and ketogenesis. II. Interactions between fatty acid oxidation and the citric acid cycle in perfused rat liver, J Biol Chem, vol.244, issue.17, pp.4617-4644, 1969.

A. Mitrakou, D. Kelley, T. Veneman, T. Jenssen, T. Pangburn et al., Contribution of Abnormal Muscle and Liver Glucose Metabolism to Postprandial Hyperglycemia in NIDDM, Diabetes, vol.39, issue.11, pp.1381-90, 1990.
DOI : 10.2337/diab.39.11.1381

J. Ryder, J. Yang, D. Galuska, J. Rincón, M. Björnholm et al., Use of a novel impermeable biotinylated photolabeling reagent to assess insulin- and hypoxia-stimulated cell surface GLUT4 content in skeletal muscle from type 2 diabetic patients, Diabetes, vol.49, issue.4, 2000.
DOI : 10.2337/diabetes.49.4.647

J. Youd, S. Rattigan, and M. Clark, Acute impairment of insulin-mediated capillary recruitment and glucose uptake in rat skeletal muscle in vivo by TNF-alpha, Diabetes, vol.49, issue.11, 2000.
DOI : 10.2337/diabetes.49.11.1904

S. Kashyap, L. Roman, J. Lamont, B. Masters, M. Bajaj et al., Insulin Resistance Is Associated with Impaired Nitric Oxide Synthase Activity in Skeletal Muscle of Type 2 Diabetic Subjects, The Journal of Clinical Endocrinology & Metabolism, vol.90, issue.2, pp.1100-1105, 2005.
DOI : 10.1210/jc.2004-0745

L. Salans, G. Bray, S. Cushman, E. Danforth, J. Glennon et al., Glucose metabolism and the response to insulin by human adipose tissue in spontaneous and experimental obesity. Effects of dietary composition and adipose cell size, J Clin Invest, 1974.

H. Bays, J. González-campoy, G. Bray, A. Kitabchi, D. Bergman et al., Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity, Expert Review of Cardiovascular Therapy, vol.91, issue.3, pp.343-68, 2008.
DOI : 10.1210/jc.2005-2069

K. Levin, H. Schroeder, F. Alford, and H. Beck-nielsen, Morphometric documentation of abnormal intramyocellular fat storage and reduced glycogen in obese patients with Type II diabetes. Diabetologia, pp.824-857, 2001.

R. Defronzo, Dysfunctional fat cells, lipotoxicity and type 2 diabetes, International Journal of Clinical Practice, vol.100, issue.Suppl. 2, pp.9-21, 2004.
DOI : 10.1249/00003677-199600240-00009

L. Groop, C. Saloranta, M. Shank, R. Bonadonna, E. Ferrannini et al., The Role of Free Fatty Acid Metabolism in the Pathogenesis of Insulin Resistance in Obesity and Noninsulin-Dependent Diabetes Mellitus*, The Journal of Clinical Endocrinology & Metabolism, vol.72, issue.1, pp.96-107, 1991.
DOI : 10.1210/jcem-72-1-96

P. Randle, P. Garland, C. Hales, and E. Newsholme, THE GLUCOSE FATTY-ACID CYCLE ITS ROLE IN INSULIN SENSITIVITY AND THE METABOLIC DISTURBANCES OF DIABETES MELLITUS, The Lancet, vol.281, issue.7285, 1963.
DOI : 10.1016/S0140-6736(63)91500-9

A. Carpentier, S. Mittelman, R. Bergman, A. Giacca, and G. Lewis, Prolonged elevation of plasma free fatty acids impairs pancreatic beta-cell function in obese nondiabetic humans but not in individuals with type 2 diabetes, Diabetes, vol.49, issue.3, pp.399-408, 2000.
DOI : 10.2337/diabetes.49.3.399

D. Ehrmann, J. Sturis, M. Byrne, T. Karrison, R. Rosenfield et al., Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus., Journal of Clinical Investigation, vol.96, issue.1, pp.520-527, 1995.
DOI : 10.1172/JCI118064

E. Ryan, S. Imes, D. Liu, R. Mcmanus, D. Finegood et al., Defects in Insulin Secretion and Action in Women With a History of Gestational Diabetes, Diabetes, vol.44, issue.5, pp.506-518, 1995.
DOI : 10.2337/diab.44.5.506

T. Wallace, J. Levy, and D. Matthews, Use and Abuse of HOMA Modeling, Diabetes Care, vol.27, issue.6, pp.1487-95, 2004.
DOI : 10.2337/diacare.27.6.1487

U. Group, UK Prospective Diabetes Study 16: overview of 6 years' therapy of type II diabetes: a progressive disease, Diabetes, vol.44, issue.11, pp.1249-58, 1995.

A. Butler, J. Janson, S. Bonner-weir, R. Ritzel, R. Rizza et al., ??-Cell Deficit and Increased ??-Cell Apoptosis in Humans With Type 2 Diabetes, Diabetes, vol.52, issue.1, pp.102-112, 2003.
DOI : 10.2337/diabetes.52.1.102

URL : http://diabetes.diabetesjournals.org/content/diabetes/52/1/102.full.pdf

G. Klöppel, M. Löhr, K. Habich, M. Oberholzer, and P. Heitz, Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited, Pathol Immunopathol Res, vol.4, issue.2, pp.110-135, 1985.

R. Pictet, W. Clark, R. Williams, and W. Rutter, An ultrastructural analysis of the developing embryonic pancreas, Developmental Biology, vol.29, issue.4, pp.436-67, 1972.
DOI : 10.1016/0012-1606(72)90083-8

C. Hellerström, I. Swenne, and A. Andersson, Islet Cell Replication and Diabetes, pp.141-70978, 1007.
DOI : 10.1007/978-3-642-72691-0_9

R. Unger, How obesity causes diabetes in Zucker diabetic fatty rats, Trends in Endocrinology and Metabolism, vol.8, issue.7, pp.276-82, 1997.
DOI : 10.1016/S1043-2760(97)00094-5

J. Höppener, B. Ahrén, and C. Lips, Islet Amyloid and Type 2 Diabetes Mellitus, New England Journal of Medicine, vol.343, issue.6, pp.411-420, 2000.
DOI : 10.1056/NEJM200008103430607

A. Grimaldi, Traité de diabétologie. Paris: Flammarion médecine-sciences, 2009.

M. Federici, M. Hribal, L. Perego, M. Ranalli, Z. Caradonna et al., High Glucose Causes Apoptosis in Cultured Human Pancreatic Islets of Langerhans: A Potential Role for Regulation of Specific Bcl Family Genes Toward an Apoptotic Cell Death Program, Diabetes, vol.50, issue.6, pp.1290-301, 2001.
DOI : 10.2337/diabetes.50.6.1290

O. Rahilly, S. Turner, R. Matthews, and D. , Impaired Pulsatile Secretion of Insulin in Relatives of Patients with Non-Insulin-Dependent Diabetes, New England Journal of Medicine, vol.318, issue.19, pp.1225-1255, 1988.
DOI : 10.1056/NEJM198805123181902

S. Kahn, D. Leonetti, R. Prigeon, E. Boyko, R. Bergstrom et al., Proinsulin as a marker for the development of NIDDM in Japanese-American men. Diabetes, 1995.

D. Drucker, The biology of incretin hormones, Cell Metabolism, vol.3, issue.3, pp.153-65, 2006.
DOI : 10.1016/j.cmet.2006.01.004

J. Meier and M. Nauck, Incretins and the development of type 2 diabetes, Current Diabetes Reports, vol.50, issue.suppl 1, pp.194-201, 2006.
DOI : 10.1152/ajpendo.00452.2001

M. Toft-nielsen, M. Damholt, S. Madsbad, L. Hilsted, T. Hughes et al., Determinants of the Impaired Secretion of Glucagon-Like Peptide-1 in Type 2 Diabetic Patients, The Journal of Clinical Endocrinology & Metabolism, vol.86, issue.8, pp.3717-3740, 2001.
DOI : 10.1210/jcem.86.8.7750

H. K. Meier, J. Holst, J. Deacon, C. Schmiegel, W. Nauck et al., Reduced insulinotropic effect of gastric inhibitory polypeptide (GIP) in first-degree relatives of type 2 diabetic patients, Diabetes Research and Clinical Practice, vol.50, issue.5, pp.227-227, 2000.
DOI : 10.1016/S0168-8227(00)81589-2

A. Cervera, E. Wajcberg, A. Sriwijitkamol, M. Fernandez, P. Zuo et al., Mechanism of action of exenatide to reduce postprandial hyperglycemia in type 2 diabetes, AJP: Endocrinology and Metabolism, vol.294, issue.5, pp.846-852, 2008.
DOI : 10.1152/ajpendo.00030.2008

G. Reaven, Y. Chen, A. Golay, A. Swislocki, and J. Jaspan, Documentation of Hyperglucagonemia Throughout the Day in Nonobese and Obese Patients with Noninsulin-Dependent Diabetes Mellitus*, The Journal of Clinical Endocrinology & Metabolism, vol.64, issue.1, pp.106-116, 1987.
DOI : 10.1210/jcem-64-1-106

M. Matsuda, R. Defronzo, L. Glass, A. Consoli, M. Giordano et al., Glucagon dose-response curve for hepatic glucose production and glucose disposal in type 2 diabetic patients and normal individuals, Metabolism, vol.51, issue.9, pp.1111-1120, 2002.
DOI : 10.1053/meta.2002.34700

M. Abdul-ghani and R. Defronzo, Inhibition of Renal Glucose Reabsorption: A Novel Strategy for Achieving Glucose Control in Type 2 Diabetes Mellitus, Endocrine Practice, vol.14, issue.6, pp.782-90, 2008.
DOI : 10.4158/EP.14.6.782

J. Brüning, D. Gautam, D. Burks, J. Gillette, M. Schubert et al., Role of brain insulin receptor and control of body weight and reproduction, Experimental and Clinical Endocrinology & Diabetes, vol.114, issue.08, pp.2122-2127, 2000.
DOI : 10.1055/s-2006-954676

M. Matsuda, Y. Liu, S. Mahankali, Y. Pu, A. Mahankali et al., Altered hypothalamic function in response to glucose ingestion in obese humans, Diabetes, vol.48, issue.9, pp.1801-1807, 1999.
DOI : 10.2337/diabetes.48.9.1801

R. Defronzo, Pathogenesis of type 2 diabetes mellitus, Med Clin, vol.88, issue.4, pp.787-835, 2004.

C. Weyer, P. Tataranni, C. Bogardus, and R. Pratley, Insulin Resistance and Insulin Secretory Dysfunction Are Independent Predictors of Worsening of Glucose Tolerance During Each Stage of Type 2 Diabetes Development, Diabetes Care, vol.24, issue.1, pp.89-94, 2001.
DOI : 10.2337/diacare.24.1.89

D. Kendall, R. Cuddihy, and R. Bergenstal, Clinical Application of Incretin-Based Therapy: Therapeutic Potential, Patient Selection and Clinical Use, The American Journal of Medicine, vol.122, issue.6, pp.37-50, 2009.
DOI : 10.1016/j.amjmed.2009.03.015

R. De, . Pratique, and . Has, Stratégie médicamenteuse du contrôle glycémique du diabète de type 2 [Internet] Available from: https://www.has-sante, pp.2013-2015, 2017.

S. Inzucchi, R. Bergenstal, J. Buse, M. Diamant, E. Ferrannini et al., Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes, Diabetes Care, vol.38, issue.1, pp.140-149, 2015.
DOI : 10.2337/dc14-2441

J. Chamberlain, W. Herman, S. Leal, A. Rhinehart, J. Shubrook et al., Pharmacologic Therapy for Type 2 Diabetes: Synopsis of the 2017 American Diabetes Association Standards of Medical Care in Diabetes, Annals of Internal Medicine, vol.166, issue.8, p.572, 2017.
DOI : 10.7326/M16-2937

S. Marshall, Precision diabetes: a realistic outlook on a promising approach, Diabetologia, vol.11, issue.5, pp.766-774, 2017.
DOI : 10.1007/s00125-017-4227-1

URL : https://link.springer.com/content/pdf/10.1007%2Fs00125-017-4244-0.pdf

B. Glaser and E. Cerasi, Early intensive insulin treatment for induction of long-term glycaemic control in type 2 diabetes, Diabetes, Obesity and Metabolism, vol.20, issue.2, pp.67-74, 1999.
DOI : 10.2337/diacare.20.9.1353

C. Kramer, B. Zinman, and R. Retnakaran, Short-term intensive insulin therapy in type 2 diabetes mellitus: a systematic review and meta-analysis, The Lancet Diabetes & Endocrinology, vol.1, issue.1, pp.28-34, 2013.
DOI : 10.1016/S2213-8587(13)70006-8

J. Buse, Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial: Design and Methods, The American Journal of Cardiology, vol.99, issue.12, pp.21-33, 2007.
DOI : 10.1016/j.amjcard.2007.03.003

B. Bauduceau, J. Doucet, and L. Bordier, Les hypoglycémies chez les diabétiques âgés : conséquences sur les fonctions cognitives. Médecine Mal Métaboliques, pp.383-390, 2011.
DOI : 10.1016/s1957-2557(11)70270-x

A. Leong, S. Berkowitz, V. Triant, B. Porneala, W. He et al., Hypoglycemia in Diabetes Mellitus as a Coronary Artery Disease Risk Factor in Patients at Elevated Vascular Risk, The Journal of Clinical Endocrinology & Metabolism, vol.101, issue.2, pp.659-68, 2016.
DOI : 10.1210/jc.2015-3169

P. Chevalier, T. Vandebrouck, D. Keyzer, D. Mertens, A. Lamotte et al., Cost and co-morbidities associated with hypoglycemic inpatients in Belgium, Journal of Medical Economics, vol.19, issue.1, pp.44-52, 2016.
DOI : 10.3111/13696998.2015.1086775

Y. Saisho, ??-cell dysfunction: Its critical role in prevention and management of type 2 diabetes, World Journal of Diabetes, vol.6, issue.1, pp.109-133
DOI : 10.4239/wjd.v6.i1.109

R. Leslie, J. Palmer, N. Schloot, and A. Lernmark, Diabetes at the crossroads: relevance of disease classification to pathophysiology and treatment, Diabetologia, vol.2, issue.1, pp.13-20, 2016.
DOI : 10.1016/S2213-8587(14)70050-6

M. Mccarthy, Painting a new picture of personalised medicine for diabetes, Diabetologia, vol.7, issue.5, pp.793-802, 2017.
DOI : 10.1126/scitranslmed.aaa9364

J. Vague, The degree of masculine differentiation of obesities a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease, Am J Clin Nutr, vol.4, issue.1, pp.20-34, 1956.

M. Modan, H. Halkin, S. Almog, A. Lusky, A. Eshkol et al., Hyperinsulinemia. A link between hypertension obesity and glucose intolerance., Journal of Clinical Investigation, vol.75, issue.3, p.809, 1985.
DOI : 10.1172/JCI111776

G. Reaven, Role of Insulin Resistance in Human Disease. Diabetes, pp.1595-607, 1988.

H. Lakka, D. Laaksonen, T. Lakka, L. Niskanen, E. Kumpusalo et al., The Metabolic Syndrome and Total and Cardiovascular Disease Mortality in Middle-aged Men, JAMA, vol.288, issue.21, pp.2709-2725, 2002.
DOI : 10.1001/jama.288.21.2709

S. Gatidis, C. Schlett, M. Notohamiprodjo, and F. Bamberg, Imaging-based characterization of cardiometabolic phenotypes focusing on whole-body MRI?an approach to disease prevention and personalized treatment Available from, Br J Radiol [Internet], vol.89, 1059.

J. Gautier, A. Mourier, E. De-kerviler, A. Tarentola, A. Bigard et al., Evaluation of Abdominal Fat Distribution in Noninsulin-Dependent Diabetes Mellitus: Relationship to Insulin Resistance, Journal of Clinical Endocrinology & Metabolism, vol.83, issue.4, pp.1306-1317, 1998.
DOI : 10.1210/jc.83.4.1306

H. Yki-järvinen, Ectopic fat accumulation: an important cause of insulin resistance in humans, J R Soc Med, vol.95, pp.39-45, 2002.

K. Cheong, S. Ghazali, L. Hock, S. Subenthiran, T. Huey et al., The discriminative ability of waist circumference, body mass index and waist-to-hip ratio in identifying metabolic syndrome: Variations by age, sex and race, Diabetes & Metabolic Syndrome: Clinical Research & Reviews, vol.9, issue.2, 2015.
DOI : 10.1016/j.dsx.2015.02.006

S. Haffner, Abdominal obesity, insulin resistance, and cardiovascular risk in pre-diabetes and type 2 diabetes, European Heart Journal Supplements, vol.8, issue.suppl_B, pp.20-25, 2006.
DOI : 10.1093/eurheartj/sul004

E. Ferrannini, G. Buzzigoli, R. Bonadonna, M. Giorico, M. Oleggini et al., Insulin Resistance in Essential Hypertension, New England Journal of Medicine, vol.317, issue.6, pp.350-357, 1987.
DOI : 10.1056/NEJM198708063170605

R. Defronzo, The effect of insulin on renal sodium metabolism. Diabetologia, pp.165-71, 1981.

F. Wang, L. Han, and D. Hu, Fasting insulin, insulin resistance and risk of hypertension in the general population: A meta-analysis, Clinica Chimica Acta, vol.464, pp.57-63, 2017.
DOI : 10.1016/j.cca.2016.11.009

G. Schillaci, M. Pirro, G. Vaudo, F. Gemelli, S. Marchesi et al., Prognostic value of the metabolic syndrome in essential hypertension, Journal of the American College of Cardiology, vol.43, issue.10, pp.1817-1839, 2004.
DOI : 10.1016/j.jacc.2003.12.049

X. Pintó, E. Corbella, P. Valdevielso, and J. Mostaza, Prevalence of metabolic syndrome in hypertriglyceridaemic patients: higher than it may appear, Current Medical Research and Opinion, vol.30, issue.2, 2014.
DOI : 10.1185/03007995.2013.856288

D. Gasevic, J. Frohlich, G. Mancini, and S. Lear, The association between triglyceride to highdensity-lipoprotein cholesterol ratio and insulin resistance in a multiethnic primary prevention cohort, Metabolism. 2012, vol.61, issue.4, pp.583-592

S. Mostafa, M. Davies, D. Morris, T. Yates, B. Srinivasan et al., The Association of the Triglyceride-to-HDL Cholesterol Ratio with Insulin Resistance in White European and South Asian Men and Women, PLoS ONE, vol.363, issue.166, p.50931, 2012.
DOI : 10.1371/journal.pone.0050931.t002

M. Smits, G. Ioannou, E. Boyko, and K. Utzschneider, Non-alcoholic fatty liver disease as an independent manifestation of the metabolic syndrome: Results of a US national survey in three ethnic groups, Journal of Gastroenterology and Hepatology, vol.54, issue.Suppl. 1, pp.664-70, 2013.
DOI : 10.1002/hep.24452

T. Yang, C. Chu, P. Hsieh, C. Hsu, Y. Chou et al., C-reactive protein concentration as a significant correlate for metabolic syndrome: a Chinese population-based study, Endocrine, vol.40, issue.suppl, pp.351-360, 2013.
DOI : 10.1007/s12020-011-9466-1

A. Mahajan, A. Jaiswal, R. Tabassum, A. Podder, S. Ghosh et al., Elevated levels of C-reactive protein as a risk factor for Metabolic Syndrome in Indians, Atherosclerosis, vol.220, issue.1, pp.275-81, 2012.
DOI : 10.1016/j.atherosclerosis.2011.10.031

J. Fernández-real, W. Ricart-engel, E. Arroyo, R. Balançá, R. Casamitjana-abella et al., Serum Ferritin as a Component of the Insulin Resistance Syndrome, Diabetes Care, vol.21, issue.1, pp.62-70, 1998.
DOI : 10.2337/diacare.21.1.62

I. Vari, B. Balkau, A. Kettaneh, P. André, J. Tichet et al., Ferritin and Transferrin Are Associated With Metabolic Syndrome Abnormalities and Their Change Over Time in a General Population: Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR), Diabetes Care, vol.30, issue.7, pp.1795-801, 2007.
DOI : 10.2337/dc06-2312

R. Defronzo, J. Tobin, and R. Andres, Glucose clamp technique: a method for quantifying insulin secretion and resistance, Am J Physiol-Gastrointest Liver Physiol, vol.237, issue.3, pp.214-223, 1979.

R. Bergman, R. Prager, A. Volund, and J. Olefsky, Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp., Journal of Clinical Investigation, vol.79, issue.3, p.790, 1987.
DOI : 10.1172/JCI112886

M. Matsuda and R. Defronzo, Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp, Diabetes Care, vol.22, issue.9, pp.1462-70, 1999.
DOI : 10.2337/diacare.22.9.1462

D. Matthews, J. Hosker, A. Rudenski, B. Naylor, D. Treacher et al., Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man, Diabetologia, vol.92, issue.7, pp.412-421, 1985.
DOI : 10.1007/BF00280883

R. Rabasa-lhoret and M. Laville, Mesurer l'insulinosensibilité en pratique clinique Available from, p.79997, 2008.

H. Yeni-komshian, M. Carantoni, F. Abbasi, and G. Reaven, Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers, Diabetes Care, vol.23, issue.2, pp.171-176, 2000.
DOI : 10.2337/diacare.23.2.171

K. Mather, A. Hunt, H. Steinberg, G. Paradisi, G. Hook et al., Repeatability Characteristics of Simple Indices of Insulin Resistance: Implications for Research Applications, The Journal of Clinical Endocrinology & Metabolism, vol.86, issue.11, pp.5457-64, 2001.
DOI : 10.1210/jcem.86.11.7880

A. Katz, S. Nambi, K. Mather, A. Baron, D. Follmann et al., Quantitative Insulin Sensitivity Check Index: A Simple, Accurate Method for Assessing Insulin Sensitivity In Humans, The Journal of Clinical Endocrinology & Metabolism, vol.85, issue.7
DOI : 10.1210/jcem.85.7.6661

P. Lefebvre, G. Paolisso, A. Scheen, and J. Henquin, Pulsatility of insulin and glucagon release: physiological significance and pharmacological implications, Diabetologia, vol.12, issue.4, pp.443-52, 1987.
DOI : 10.1007/978-3-642-68866-9_13

H. Rasmussen, K. Zawalich, S. Ganesan, R. Calle, and W. Zawalich, Physiology and Pathophysiology of Insulin Secretion, Diabetes Care, vol.13, issue.6, pp.655-66, 1990.
DOI : 10.2337/diacare.13.6.655

D. Prato, S. Tiengo, and A. , The importance of first-phase insulin secretion: implications for the therapy of type 2 diabetes mellitus, Diabetes/Metabolism Research and Reviews, vol.18, issue.3, pp.164-74, 2001.
DOI : 10.2337/diacare.18.8.1156

K. Polonsky and A. Rubenstein, Current approaches to measurement of insulin secretion, Diabetes / Metabolism Reviews, vol.66, issue.1, pp.3-4315, 1986.
DOI : 10.2337/diab.27.1.S197

M. Castillo, A. Scheen, M. Letiexhe, and P. Lefèbvre, How to measure insulin clearance, Diabetes / Metabolism Reviews, vol.38, issue.2, pp.119-50, 1994.
DOI : 10.1111/j.1532-5415.1990.tb03449.x

R. Temple, P. Clark, and C. Hales, Measurement of Insulin Secretion in Type 2 Diabetes: Problems and Pitfalls, Diabetic Medicine, vol.34, issue.suppl 1, pp.503-515, 1992.
DOI : 10.1042/bj2600535

A. Covic, J. Schelling, M. Constantiner, S. Iyengar, and J. Sedor, Serum C-peptide concentrations poorly phenotype type 2 diabetic end-stage renal disease patients, Kidney International, vol.58, issue.4, pp.1742-50, 2000.
DOI : 10.1046/j.1523-1755.2000.00335.x

URL : https://doi.org/10.1046/j.1523-1755.2000.00335.x

P. Clark, Assays for Insulin, Proinsulin(S) and C-Peptide, Annals of Clinical Biochemistry: An international journal of biochemistry and laboratory medicine, vol.36, issue.5, pp.541-64, 1999.
DOI : 10.1177/000456329903600501

URL : http://journals.sagepub.com/doi/pdf/10.1177/000456329903600501

M. Albareda, M. Rigla, J. Rodriguez-espinosa, A. Caballero, A. Chico et al., Influence of exogenous insulin on C-peptide levels in subjects with type 2 diabetes, Diabetes Research and Clinical Practice, vol.68, issue.3, pp.202-208, 2005.
DOI : 10.1016/j.diabres.2004.10.005

H. Gjessing, L. Matzen, A. Frøland, and O. Faber, Correlations Between Fasting Plasma C-Peptide, Glucagon-Stimulated Plasma C-Peptide, and Urinary C-Peptide in Insulin-Treated Diabetics, Diabetes Care, vol.10, issue.4, pp.487-90, 1987.
DOI : 10.2337/diacare.10.4.487

H. Wiedmeyer, K. Polonsky, G. Myers, R. Little, C. Greenbaum et al., International Comparison of C-Peptide Measurements, Clinical Chemistry, vol.53, issue.4, pp.784-791, 2007.
DOI : 10.1373/clinchem.2006.081570

URL : http://clinchem.aaccjnls.org/content/clinchem/53/4/784.full.pdf

R. Little, C. Rohlfing, A. Tennill, R. Madsen, K. Polonsky et al., Standardization of C-Peptide Measurements, Clinical Chemistry, vol.54, issue.6, pp.1023-1029, 2008.
DOI : 10.1373/clinchem.2007.101287

URL : http://clinchem.aaccjnls.org/content/clinchem/54/6/1023.full.pdf

R. Faradji, K. Monroy, S. Messinger, A. Pileggi, T. Froud et al., Simple Measures to Monitor ?-Cell Mass and Assess Islet Graft Dysfunction, American Journal of Transplantation, vol.7, issue.2, pp.303-311, 2007.
DOI : 10.1152/ajpendo.00319.2003

URL : http://onlinelibrary.wiley.com/doi/10.1111/j.1600-6143.2006.01620.x/pdf

Y. Okuno, H. Komada, K. Sakaguchi, T. Nakamura, N. Hashimoto et al., Postprandial serum C-peptide to plasma glucose concentration ratio correlates with oral glucose tolerance test- and glucose clamp-based disposition indexes, Metabolism, vol.62, issue.10, pp.1470-1476, 2013.
DOI : 10.1016/j.metabol.2013.05.022

Y. Saisho, K. Kou, K. Tanaka, T. Abe, H. Kurosawa et al., Postprandial serum C-peptide to plasma glucose ratio as a predictor of subsequent insulin treatment in patients with type 2 diabetes, Endocrine Journal, vol.58, issue.4, pp.315-337, 2011.
DOI : 10.1507/endocrj.K10E-399

E. Lee, S. Hwang, S. Lee, Y. Lee, A. Choi et al., Postprandial C-peptide to glucose ratio as a predictor of ??-cell function and its usefulness for staged management of type??2 diabetes, Journal of Diabetes Investigation, vol.22, issue.Suppl, pp.517-541, 2014.
DOI : 10.2337/diacare.10.5.558

P. Lefebvre and A. Luyckx, The breakfast tolerance test: a return to physiology, Diabete Metab, vol.2, issue.1, pp.15-24, 1976.

S. Shankar, A. Vella, R. Raymond, M. Staten, R. Calle et al., Standardized Mixed-Meal Tolerance and Arginine Stimulation Tests Provide Reproducible and Complementary Measures of ??-Cell Function: Results From the Foundation for the National Institutes of Health Biomarkers Consortium Investigative Series, Diabetes Care, vol.39, issue.9, 2016.
DOI : 10.2337/dc15-0931

C. Guglielmi, D. Toro, R. Lauria, A. Maurizi, A. Fallucca et al., Effect of GLP-1 and GIP on C-peptide secretion after glucagon or mixed meal tests: Significance in assessing B-cell function in diabetes, Diabetes/Metabolism Research and Reviews, vol.31, issue.6, 2017.
DOI : 10.1002/dmrr.2647

P. Koskinen, J. Viikari, and K. Irjala, Glucagon-Stimulated and Postprandial Plasma C-Peptide Values as Measures of Insulin Secretory Capacity, Diabetes Care, vol.11, issue.4, pp.318-340, 1988.
DOI : 10.2337/diacare.11.4.318

Y. Fujioka, T. Okura, K. Sumi, K. Matsumoto, K. Shoji et al., Normal meal tolerance test is preferable to the glucagon stimulation test in patients with type 2 diabetes that are not in a hyperglycemic state: Comparison with the change of C-peptide immunoreactivity, Journal of Diabetes Investigation, vol.128, 2017.
DOI : 10.7326/0003-4819-128-7-199804010-00001

S. Paglialunga, A. Guerrero, J. Roessig, P. Rubin, and C. Dehn, Adding to the spectrum of insulin sensitive populations for mixed meal tolerance test glucose reliability assessment Available from, J Diabetes Metab Disord [Internet], vol.15, 2016.

D. Phillips, P. Clark, C. Hales, and O. C. , Understanding Oral Glucose Tolerance: Comparison of Glucose or Insulin Measurements During the Oral Glucose Tolerance Test with Specific Measurements of Insulin Resistance and Insulin Secretion, Diabetic Medicine, vol.51, issue.3, pp.286-92, 1994.
DOI : 10.1042/bj2600535

Y. Saisho, K. Kou, K. Tanaka, T. Abe, A. Shimada et al., Postprandial serum C-peptide to plasma glucose ratio predicts future insulin therapy in Japanese patients with type 2 diabetes):987. serum C-peptide value is the optimal index to identify patients with non-obese type 2 diabetes who require multiple daily insulin injection: Analysis of C-peptide values before and after short-term intensive insulin therapy, Acta Diabetol. J Diabetes Investig, vol.504, issue.66, pp.618-643, 2013.

Y. Saisho, K. Kou, K. Tanaka, T. Abe, A. Shimada et al., Association between beta cell function and future glycemic control in patients with type 2 diabetes, Endocrine Journal, vol.60, issue.4, pp.517-540, 2013.
DOI : 10.1507/endocrj.EJ12-0416

J. Meier, B. Menge, T. Breuer, C. Müller, A. Tannapfel et al., Functional Assessment of Pancreatic ??-Cell Area in Humans, Diabetes, vol.58, issue.7, pp.1595-603, 2009.
DOI : 10.2337/db08-1611

S. Funakoshi, S. Fujimoto, A. Hamasaki, H. Fujiwara, Y. Fujita et al., Utility of indices using C-peptide levels for indication of insulin therapy to achieve good glycemic control in Japanese patients with type???2 diabetes, Journal of Diabetes Investigation, vol.58, issue.4, pp.297-303, 2011.
DOI : 10.2337/db08-1611

Y. Saisho, Postprandial C-Peptide to Glucose Ratio as a Marker of ?? Cell Function: Implication for the Management of Type 2 Diabetes, International Journal of Molecular Sciences, vol.44, issue.5, p.744, 2016.
DOI : 10.1210/jc.2016-1374

K. Yoon, J. Lee, J. Kim, J. Cho, Y. Choi et al., Epidemic obesity and type 2 diabetes in Asia, The Lancet, vol.368, issue.9548, pp.1681-1689, 2006.
DOI : 10.1016/S0140-6736(06)69703-1

J. Chan, N. Cho, N. Tajima, and J. Shaw, Diabetes in the Western Pacific Region???Past, Present and Future, Diabetes Research and Clinical Practice, vol.103, issue.2, pp.244-55, 2014.
DOI : 10.1016/j.diabres.2013.11.012

A. Luk, E. Lau, W. So, R. Ma, A. Kong et al., Prospective Study on the Incidences of Cardiovascular-Renal Complications in Chinese Patients With Young-Onset Type 1 and Type 2 Diabetes, Diabetes Care, vol.37, issue.1, pp.149-57, 2014.
DOI : 10.2337/dc13-1336

M. Kelly, J. Chan, J. Heward, C. Mijovic, P. Zimmet et al., HLA typing and immunological characterization of young-onset diabetes mellitus in a Hong Kong Chinese population, Diabetic Medicine, vol.19, issue.1, pp.22-30, 2001.
DOI : 10.1016/S0140-6736(97)03062-6

C. Tanaka, Y. Saisho, K. Tanaka, K. Kou, M. Tanaka et al., Factors associated with glycemic variability in Japanese patients with diabetes, Diabetology International, vol.33, issue.1, pp.36-42
DOI : 10.1007/s00592-012-0441-y

T. Iwao, K. Sakai, and M. Sata, Postprandial serum C-peptide is a useful parameter in the prediction of successful switching to liraglutide monotherapy from complex insulin therapy in Japanese patients with type 2 diabetes, Journal of Diabetes and its Complications, vol.27, issue.1, pp.87-91, 2013.
DOI : 10.1016/j.jdiacomp.2012.07.001

G. Kim, Y. Lee, E. Kang, B. Cha, H. Lee et al., Characteristics Predictive for a Successful Switch from Insulin Analogue Therapy to Oral Hypoglycemic Agents in Patients with Type 2 Diabetes, Yonsei Medical Journal, vol.57, issue.6, p.1395, 2016.
DOI : 10.3349/ymj.2016.57.6.1395

B. Kim, C. Jung, J. Mok, and C. Kim, Factors Associated with Long-Term Oral Hypoglycemic Agent Responsiveness in Korean Patients with Type 2 Diabetes Mellitus, Diabetes & Metabolism Journal, vol.35, issue.3, pp.282-291, 2011.
DOI : 10.4093/dmj.2011.35.3.282

L. Hermann, B. Schersten, and A. Melander, Antihyperglycaemic Efficacy, Response Prediction and Dose-Response Relations of Treatment with Metformin and Sulphonylurea, Alone and in Primary Combination, Diabetic Medicine, vol.16, issue.supplement, pp.953-60, 1994.
DOI : 10.1111/j.1445-5994.1991.tb01375.x

M. Moore, T. Dougall, J. Ferguson, P. Rigsby, and C. Burns, Conclusions:, Clinical Chemistry and Laboratory Medicine (CCLM), vol.54, issue.8, pp.1224-1257, 2017.
DOI : 10.1515/cclm-2017-0029